Back to Search
Start Over
Phase I clinical trial to assess the safety of pNGVL4aCRTE6E7L2 DNA and TA-CIN protein vaccinations and to seek the appropriate dose of the pNGVL4aCRTE6E7L2 DNA vaccine.
- Source :
-
Gynecologic Oncology . 2024 Supplement 1, Vol. 190, pS294-S294. 1p. - Publication Year :
- 2024
- Subjects :
- *DNA vaccines
*CLINICAL trials
*VACCINATION
*DNA
*PROTEINS
Subjects
Details
- Language :
- English
- ISSN :
- 00908258
- Volume :
- 190
- Database :
- Academic Search Index
- Journal :
- Gynecologic Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 180154347
- Full Text :
- https://doi.org/10.1016/j.ygyno.2024.07.439